Europe Market News

Germany's Factory Confidence Turns Positive as Services Slip

Germany's ifo index rose for a sixth month as manufacturing expectations improved, but weaker current conditions and a services setback show that the recovery remains narrow and exposed to energy risks.

Mondelez's Volume Recovery Lifts Margins, but Europe Still Shrinks

Mondelez's third-quarter volume recovery and 380-basis-point adjusted gross-margin expansion lifted the shares, but Europe's organic sales contraction and unchanged full-year guidance show the rebound is uneven.

Enphase's Q4 Forecast Shows the Solar Slump Is Deepening

Enphase's fourth-quarter revenue midpoint is about 18% below Q3 as U.S. and European demand weakens. Cash remains substantial, but margins and near-term shipments are contracting.

Critical Metals' Acquisition Creates a Dilution Test

Critical Metals will issue stock to acquire European Lithium, but the final share increase is not yet disclosed. The November trading debut will test selling pressure while both flagship projects still need funding.

Volkswagen's China Software Proposal Tests Rivian's Partnership Scope

Volkswagen is reportedly considering China-developed software for much of its European lineup, but no decision has been made and its $5.8 billion Rivian venture continues to reach milestones.

IREN's 300MW Spain Campus Adds Capacity and a Funding Test

IREN secured a civil works license for a 300MW Spanish AI campus targeted for 2028. The project expands its European reach, but customer commitments and financing remain unresolved.

IREN's 300MW Spain Campus Is a 2028 Funding Test

IREN secured a civil-works license and grid power for a planned 300MW campus in Spain. The project expands its European reach, but customers, financing and revenue remain years away.

Stellantis Improves Margins, but Cash Flow Remains the Real Test

Stellantis narrowed its loss and reaffirmed guidance, yet negative €4.01 billion industrial free cash flow, a European loss and Canadian labor risk keep the turnaround unfinished.

Krystal Biotech's International Sales Now Carry VYJUVEK Growth

Krystal Biotech's VYJUVEK revenue rose 24% in the second quarter, but U.S. sales slipped as Europe and Japan supplied the growth. Pipeline data and international execution now carry more weight.

Critical Minerals Rally Masks Three Very Different Execution Risks

United States Antimony filed a Nolan Creek resource report as Critical Metals advanced its European Lithium transaction. The rally is real, but resource economics, dilution and project funding remain unresolved.

Latvia Expands Tesla's European Reach, but Assisted Driving Still Requires Supervision

Latvia became the tenth European country to authorize Tesla's driver-assistance software, widening its addressable market while safety interventions and a delayed EU-wide vote limit the immediate payoff.

LKQ's Guidance Withdrawal Is the Real Signal in a Three-Stock Selloff

T-Mobile, LKQ and Chipotle reached multiyear lows for different reasons. LKQ's withdrawn guidance and Europe disruption carry the clearest company-specific evidence, while the other moves depend on still-unresolved competitive and earnings questions.

Nebius's Reported €250 Million French Raise Leaves Key Terms Unclear

A reported €250 million raise may support Nebius's 240-megawatt French AI factory, but the undisclosed structure prevents investors from measuring dilution, leverage or project returns.

Britain's Apprenticeship Shift Raises the Cost of Training Older Workers

Britain is steering apprenticeship support toward younger workers while asking employers to pay more for over-25 training. The policy may increase youth hiring, but it also risks reducing mid-career reskilling.

France's Budget Stress Test Now Includes Street Unrest

France's protests are adding an economic risk to an already difficult 2027 budget. Investors must separate temporary disruption from the harder question of whether the government can deliver deficit reduction without weakening growth.